<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are aggressive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of B-cell origin </plain></SENT>
<SENT sid="1" pm="."><plain>In some cases they arise from low-grade follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> carrying the t(14;18) translocation, an event that leads to the overexpression of the BCL-2 gene product </plain></SENT>
<SENT sid="2" pm="."><plain>More frequently, however, they lack the t(14;18) translocation </plain></SENT>
<SENT sid="3" pm="."><plain>Rearrangements of the c-MYC proto-oncogene and mutations of the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene have also been documented in these <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This study examines the extent to which alterations in the BCL-2, c-MYC, and p53 genes co-exist within individual <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Eight diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines and 11 diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were assessed for genetic alterations in these three genes </plain></SENT>
<SENT sid="6" pm="."><plain>Our results indicate that there is a <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in the oncogene/suppressor gene profile among diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Two cell lines and one <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> carried alterations in <z:hpo ids='HP_0000001'>all</z:hpo> three genes, one cell line carried alterations of c-MYC and p53, and one <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and one cell line carried p53 mutations and the t(14;18) </plain></SENT>
<SENT sid="8" pm="."><plain>Single alterations of BCL-2 and p53 were also observed </plain></SENT>
<SENT sid="9" pm="."><plain>Another cell line had no alterations in any of these genes </plain></SENT>
<SENT sid="10" pm="."><plain>The <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> indicates that varied mechanisms may be involved in the generation of diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>